Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Advocating, auditor, challenge, Cherry, composition, Creek, Denver, deputy, Donald, era, ethnic, facilitate, fax, filling, fundraising, hard, hemophilia, Hesheng, highest, inpatient, light, lowest, Maternity, MIDL, migrating, mixed, officially, partly, PCAOB, perspective, prepaid, Printing, progression, psychotropic, reshuffle, risen, rough, roughly, shuffling, slightly, slower, South, spotlight, theme, Trump, undergone, unreasonable, urge, Wang, withdrawn
Removed:
adjustment, arshak, calculation, ceiling, constitute, davtyan, decisive, designing, deviate, elimination, enrolled, factor, fall, Frisco, hypothetical, maturity, measurement, moving, NDRC, notification, obsolescence, output, Parkway, peculiarity, premium, real, removed, revolving, shift, Undistributed
Filing tables
Filing exhibits
Associated CPHI transcripts
CPHI similar filings
Filing view
External links
Exhibit 10.5
Loans Extension Confirmation Letter
Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD84,849.59 respectively as of December 31, 2017. Due to the fact the Company temporarily did not have enough balance in its oversea account to repay the loans, both Ms. Tsui and the Company agreed to extend the loans to December 31, 2018, by which date the Company shall repay the principal and accumulated interest.
Creditor: /s/ Heung Mei Tsui
Debtor: China Pharma Holdings, Inc.
By: Zhilin Li, President & CEO